JRCT ID: jRCT2080223561
Registered date:16/06/2017
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 28/06/2017 |
Target sample size | 2 |
Countries of recruitment | Japan,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety pharmacokinetics |
---|---|
Secondary Outcome | pharmacodynamics |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | <= 65age old |
Gender | Male |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NTC02571569,JapicCTI-173617 |
Contact
Public contact | |
Name | |
Address | |
Telephone | - |
byl_ct_contact@bayer.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
byl_ct_contact@bayer.com | |
Affiliation |